Corneal Transplant Follow-up Study II: a randomised trial to determine whether HLA class II matching reduces the risk of allograft rejection in penetrating keratoplasty.

Armitage, W John; Winton, Helen L; Jones, Mark N A; Downward, Lewis; Crewe, Julie M; Rogers, Chris A; Tole, Derek M; Dick, Andrew D

Armitage, W John; Winton, Helen L; Jones, Mark N A; Downward, Lewis; Crewe, Julie M; Rogers, Chris A; Tole, Derek M; Dick, Andrew D.

Afiliación

Armitage WJ; Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK w.j.armitage@bristol.ac.uk.
Winton HL; Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Jones MNA; NHS Blood and Transplant, Bristol, UK.
Downward L; NHS Blood and Transplant, Bristol, UK.
Crewe JM; Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Rogers CA; Bristol Trials Centre, Bristol Medical School, University of Bristol, Bristol, UK.
Tole DM; Bristol Eye Hospital, Bristol, UK.
Dick AD; Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Br J Ophthalmol ; 106(1): 42-46, 2022 01.

Article en En | MEDLINE | ID: mdl-33268345

Asunto(s)

Catarata; Trasplante de Córnea; Aloinjertos; Estudios de Seguimiento; Rechazo de Injerto/prevención & control; Supervivencia de Injerto; Prueba de Histocompatibilidad; Humanos; Queratoplastia Penetrante

Palabras clave

HLA class II; HLA matching; allograft rejection; corneal transplantation; immunological rejection

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Catarata / Trasplante de Córnea Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Br J Ophthalmol Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google